BMS-986393
A Study of BMS-986393 (CC-95266) in Subjects With Relapsed and/or Refractory Multiple Myeloma
More Information
- Trial Status
- Active, Not Recruiting
- Trial Phase
- Phase 1
- Enrollment
- 75 patients (estimated)
- Sponsors
- Juno Therapeutics, a Subsidiary of Celgene
- Tags
- CAR T Cell, GPRC5D
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1151
- NCT Identifier
- NCT04674813
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.